The roles of patients, patient advocates, and other members of the public in decision-making about the research that is funded by NIH and other agencies here in America is sadly somewhat limited, … READ MORE …
Filed under: Uncategorized | Tagged: NIH, opinion, patient, research | Leave a comment »
A report yesterday on on the MedPage Today web site quotes Scott Gottlieb, MD, the Commissioner of the U.S. Food & Drug Administration (FDA) on the importance of “Listening to patients” and on how patients’ perspectives can inform drug development, drug review, and physicians’ prescribing habits. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: development, drug, opinion, patient, regulation | 1 Comment »
One has to sign up to become a member of the UroToday web site, but there is no cost involved, and an attractive feature for prostate cancer patients is the regular, relatively brief, video-recorded interviews with experts on recent, specific issues. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: expert, interview, opinion, video | 1 Comment »
In a new article in the Journal of Urology, researchers at Johns Hopkins Medical Center in Baltimore have again expressed their opinion that it would be inappropriate to rename low-risk Gleason 6 disease as something other than “cancer”. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: cancer, IMPACT, not, opinion, terminology | 3 Comments »
For those who really want all the details, the full text of the report from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017 is now available on line. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: advanced, consensus, opinion | 2 Comments »
Editorial note: The following is an anonymous commentary that has been posted twice to this web site in recent days. Parts of it are factually accurate. Some of it is certainly factually inaccurate. Most of it appears to refer to the situation here in America. And a lot of it is personal opinion (as the author states). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Diagnosis, opinion, over-treatment, personal, risk, Treatment | 18 Comments »
An interesting new paper published this morning in Cancer has shown that while lots of men have been getting second opinions from urologists on what to do about a diagnosis of prostate cancer, those second opinions don’t seem to have had much impact on their care. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: decision, opinion, risk, second, Treatment | 9 Comments »
Apparently, early in 2015, there was a major international consensus conference, among nearly 50 of the leading international authorities, on the treatment of advanced prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: advanced, conference, consensus, expert, opinion | Leave a comment »
The statements that you will find below represent the “expert opinion” of a multinational group of specialists who have been using focal therapy investigationally in the treatment of men with certain types of prostate cancer in recent years. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: expert, focal, opinion, therapy | Leave a comment »
According to newly published data in JAMA Internal Medicine and discussed on the Reuters web site today, “physician characteristics may play a larger role than disease characteristics when it comes to how patients with low-risk prostate cancer are initially treated.” This won’t come as a big surprise to most experienced prostate cancer advocates. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: bias, low risk, necessity, opinion, Treatment | 2 Comments »
Many readers of this news blog may want to listen to or read Dr. Gerald Chodak’s latest video blog on the Medscape Oncology web site. … READ MORE …
Filed under: Uncategorized | Tagged: evidence, opinion, patient, physician, relations, truth | 1 Comment »
A misleadingly titled op-ed in Forbes magazine this week by two very committed prostate cancer surgeons reflects the sad lack of reality exhibited by some representatives of the clinical treatment community. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: CyberKnife, fact, localized, opinion, RALP | 7 Comments »
According to a new study published on line in Prostate Cancer and Prostatic Diseases, 370/425 urologists who responded to a recent survey felt that active surveillance was a reasonable management strategy and about 350/425 actually manage patients by using this approach. But … READ MORE …
Filed under: Living with Prostate Cancer, Management, Uncategorized | Tagged: acceptance, active surveillance, opinion, urologist | 19 Comments »
We aren’t sure exactly what this adds to the recent conversations, but Gallup, the market research firm, has just provided results of a poll that asked 1,102 upstanding American adults for their opinions about cancer screening. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Gallup, opinion, perception, public, screening | 9 Comments »
An article by a highly regarded specialist in medical oncology in the most recent issue of The ASCO Post discusses recent recommendations from the U.S. Preventive Services Task Force (USPSTF). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, opinion, recommendation, risk, USPSTF | 11 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 